Perspectives: Opinions from our network of advisors, investors, operators and analysts on the risks and opportunities they see.
The web of regulatory and individual privacy requirements in the U.S. makes it extremely difficult to be innovative in the healthcare sector.
Even so, digital pharmacies are trying to challenge brick-and-mortar competitors in the almost $300 billion pharmacy market by promising cost savings, convenience and greater access for consumers for whom a trip to the drugstore is a difficult thing.
Nicole DiMaria, a member of New Jersey-based Chiesa Shahinian & Giantomasi PC, provides healthcare corporate and regulatory counseling as part of the firm’s Healthcare and Hospitals Group. She spoke with Karma Network’s Contributing Editor Michael Moran about the regulatory and consumer trust issues facing digital pharmacies and what factors might influence whether impact investors jump in.